Icosapent ethyl (Vascepa) for severe hypertriglyceridemia

Medical Letter on Drugs and Therapeutics

Volumn 55, Issue 1415, 2013, Pages 33-34

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; DOCOSAHEXAENOIC ACID; FIBRIC ACID DERIVATIVE; FISH OIL; GEMFIBROZIL; GLAXO SMITHKLINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID ETHYL ESTER; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; OMEGA 3 ACID ETHYL ESTER; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; DRUG DERIVATIVE;

ARTICLE; BLEEDING TIME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DRUG OVERDOSE; DYSPEPSIA; ERUCTATION; HUMAN; HYPERTRIGLYCERIDEMIA; PANCREATITIS; PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; RHABDOMYOLYSIS; RISK FACTOR; SIDE EFFECT; TASTE DISORDER; THROMBOCYTE AGGREGATION INHIBITION; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMISTRY; CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; PROCEDURES; SEVERITY OF ILLNESS INDEX; METHODOLOGY; REVIEW;

ANIMALS; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HUMANS; HYPERTRIGLYCERIDEMIA; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 84876889372     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia. Med Lett Drugs Ther 2005; 47:91.
2. Fish oil supplements. Med Lett Drugs Ther 2012; 54:83.
3. Drugs for hypertriglyceridemia. Med Lett Drugs Ther 2013; 55:17.
4. HE Bays et al. Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the multi-center, placebo-controlled, randomized, double-blind, 12-week study with an open-label extension [MARINE] trial). Am J Cardiol 2011; 108:682.
5. CM Ballantyne et al. Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study). Am J Cardiol 2012; 110:984.
6. TA Jacobson et al. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review. J Clin Lipidol 2012; 6:5.